Pregnancy,lupus and antiphospholipid syndrome (Hughes syndrome)

Abstract

Autoimmune diseases (AD) occur frequently in women during their childbearing years and may influence pregnancy outcome and neonatal health. Patients with systemic lupus erythematosus (SLE) can experience a disease flare-up during pregnancy with potential negative effects on the product of conceptus, especially if the disease is active. Recurrent pregnancy loss is now considered as a treatable clinical condition associated with the presence of circulating antiphospholipid antibodies (aPL). The neonatal lupus syndromes (NLS), caused by the transplacental passage of maternal IgG anti-Ro/SS-A and anti-La/SS-B antibodies to the fetus, carry significant morbidity and mortality in case of cardiac manifestations. Immunosuppressive agents are often administered during pregnancy in order to control maternal disease and to ensure a better pregnancy outcome. Nowadays, owing to our increasing knowledge of the disease pathophysiological mechanisms and the development of combined medical-obstetric clinics, pregnancy outcome in patients with AD has notably improved.

Keywords

antiphospholipid syndrome immunosuppressive drugs neonatal lupus syndrome pregnancy systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Lockshin M , Sammaritano L. Lupus pregnancy . Autoimmunity 2003; 36: 33-40 .

Kitridou RC. The mother in systemic lupus erythematosus. In Wallace DJ , Hahn BH , eds. Dubois’ Lupus Erythematosus. Fifth edition.

Lippincott, Williams & Wilkins

1997; 967-1002.

Buchanan NMM , Khamashta MA , Kerslake S , Hunt BJ , Hughes GRV. Practical management of pregnancy in systemic lupus erythematosus . Foetal Mat Med Rev 1993; 5: 223-230 .

Clowse MEB , Magder L , Petri M. Impact of the intensity and timing of lupus activity on pregnancy outcomes . Arthritis Rheum 2003; 48: S435-S435 .

Branch DW , Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies . Obstetrics and Gynecology 2003; 101: 1333-1344 .

Buyon JP , Clancy RM. Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based research Registry for Neonatal Lupus . Autoimmunity 2003; 36: 41-50 .

Gonzales-Crespo MR , Gomez-Reino JJ , Merino R et al. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide . Br J Rheumatol 1995; 34: 737-741 .

Lockshin MD , Reinitz E , Druzin ML et al. Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy . Am J Med 1984; 77: 893-898 .

Tincani A , Faden D , Tarantini M et al. Systemic lupus erythematosus and pregnancy: a prospective study . Clin Exp Rheumatol 1992; 10: 439-446 .

10.

Tandon A , Ibanez D , Gladman DD et al. The effect of pregnancy on lupus nephritis . Arthritis Rheum 2004; 12: 3941-3946 .

11.

Ruiz-Irastorza G , Lima F , Alves J et al. Increased rate of lupus flare during pregnancy and puerperium: a prospective study of 78 pregnancies . Br J Rheumatol 1996; 35: 133-138 .

12.

Petri M. Prospective study of systemic lupus erythematosus pregnancies . Lupus 2004; 13: 688-689 .

13.

Doria A , Vescovi V , Iaccarino L et al.

Pregnancy in SLE (1): is it possible to predict disease flare?

Arthritis Rheum 2002; 812: S322-S322 (abstract).

14.

Tincani A , Faden D , Biasini-Rebaioli C et al.

Pregnancy in SLE (2): is it possible to predict gestational outcome?

Arthritis Rheum 2002; 812: S322-S322 (abstract).

15.

Branch DW. Pregnancy in patients with rheumatic diseases: obstetric management and monitoring . Lupus 2004; 13: 696-698 .

16.

Thureen PJ , Anderson MS , Hay WW. The small-for-gestational-age infant . Neo Reviews 2001; 2: 139-149 .

17.

Ross G , Sammaritano L , Nass R et al. Effects of mothers’ autoimmune disease during pregnancy on learning disabilities and hand preference in their children . Arch Pediatr Adolesc Med 2003; 157: 397-402 .

18.

Lahita RG. Systemic lupus erythematosus: learning disabilities in the male offspring of female patients and relationship to laterality . Psychoneuroendocrinology 1988; 13: 385-396 .

19.

Gualtieri T , Hicks RE. An immunoreactive theory of selective male affliction . Behav Brain Sci 1985; 8: 427-441 .

20.

Murashima A , Fukazawa T , Hirashima M. Long term prognosis of children born to lupus patients . Ann Rheum Dis 2004; 63: 50-53 .

21.

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309-1311 .

22.

Cervera R , Piette JC , Font J et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients . Arthritis Rheum 2002; 46: 1019-1027 .

23.

Tincani A , Spatola L , Cinquini M , Meroni PL , Balestrieri G , Shoenfeld Y. Animal models of antiphospholipid syndrome . Rev Rheum 1998; 56: 614-618 .

24.

Meroni PL , Riboldi P. Pathogenic mechanisms mediating antiphospholipid syndrome . Curr Opin Rheumatol 2001; 13: 377-382 .

25.

Rand JH , Wu XX , Guller S. Reduction of annexin V (placental anticoagulant protein I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion . Am J Obstet Gynecol 1994; 171: 1566-1572 .

26.

Di Simone N , Meroni PL , Del Papa N. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-Glicoprotein I . Arthritis Rheum 2000; 43: 140-150 .

27.

Meroni PL , Di Simone N , Testoni C et al. Antiphospholipid antibodies as cause of pregnancy loss . Lupus 2004; 13: 649-652 .

28.

Tincani A , Lojacono A , Taglietti M et al. Pregnancy and neonatal outcome in primary antiphospholipid syndrome . Lupus 2002; 11: 649-649 .

29.

Boffa MC , Aurousseau MH , Lachassinne E et al. European register of babies born to mothers with antiphospholipid syndrome . Lupus 2004; 13: 713-717 .

30.

Lojacono A , Spatola L , Faden D et al. Foetal Stroke Associated with maternal antiphospholipid antibodies: a case report . Lupus 1996; 5: 512-512 .

31.

Riboldi PS , Gerosa M , Tincani A et al. Non organ specific autoimmunity involvement in cardiovascular disease. In Doria A and Pauletto P eds. The heart in systemic autoimmune diseases. Elsevier Science 2004: 41-51.

32.

Avcin T , Cimaz R , Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations . Lupus 2002; 11: 4-10 .

33.

Neri F , Chimini L , Bonomi F et al. Neuropsychological development of children born to patients with systemic lupus erythematosus . Lupus 2004; 13: 805-811 .

34.

Ziporen L , Shoenfeld Y , Levy Y et al. Neurological dysfunctions and hyperactive behavior associated with antiphospholipid antibodies . J Clin Invest 1997; 100: 613-619 .

35.

Meroni PL , Tincani A , Sepp N et al. Endothelium and brain . Lupus 2003; 12: 919-928 .

36.

Lee LA , Sokol RJ , Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry . Pediatrics 2002; 109: 11-11 .

37.

Cimaz R , Spence DL , Hornberger L et al. Incidence and spectrum of neonatal lupus erythematous: a prospective study of infant born to mothers with anti-Ro antibodies . J Pediatr 2003; 142: 678-683 .

38.

Hull RG , Harris EN , Morgan SH , Hughes GR. Anti-Ro antibodies and abortions in women with SLE . Lancet 1983; 2: 1138-1138 .

39.

Mavragani CP , Dafni UG , Tzioufas AG , Moutsopoulos HM. Pregnancy outcome and anti-Ro/SS-A in autoimmune diseases: a retrospective cohort study . Br J Rheumatol 1998; 37: 740-745 .

40.

Brucato A , Doria A , Frassi M et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SS-A antibodies: a prospective controlled study . Lupus 2002; 11: 716-721 .

41.

Kertesz NJ , Fenrich AL , Friedman RA. Congenital complete atrioventricular block . Texas Heart Inst J 1997; 24: 301-307 .

42.

Brucato A , Frassi M , Franceschini F et al. Congenital heart block risk to newborns of mothers with anti-Ro/SSA antibodies detected by counter-immunoelectrophoresis. A prospective study of 100 women . Arthritis Rheum 2001; 44: 1832-1835 .

43.

Buyon JP , Clancy RM. Neonatal lupus syndromes . Lupus 2004; 13: 705-712 .

44.

Solomon DG , Rupel A , Buyon JP. Birth order and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling . Lupus 2003; 12: 646-647 .

45.

Buyon JP , Waltuck J , Kleinman C , Copel J. In utero identification and therapy of congenital heart block (CHB) . Lupus 1995; 4: 116-121 .

46.

Sonesson SE , Salomonsson S , Jacobsson LA et al. Signs of first-degree heart block occur in one-third of foetuses of pregnant women with anti-SSA/Ro 52-kd antibodies . Arthritis Rheum 2004; 50: 1253-1261 .

47.

Buyon JP , Hiebert R , Copel J et al. Autoimmune-associated congenital heart block: mortality, mobidity and recurrence rates obtained from a national neonatal lupus registry . J Am Coll Cardiol 1998; 31: 1658-1666 .

48.

Behan P , Geschwind N. Dyslexia, congenital anomalies and immune disorders. The role of the fetal environment . Ann N Y Acad Sci 1985; 457: 13-18 .

49.

Denenberg VH. Effects of the autoimmune uterine/maternal environment upon cortical ectopia, behavior and autoimmunity . Brain Res 1991; 563: 114-122 .

50.

Martin V , Lee LA , Askanase AD et al. Long term follow-up of children with neonatal lupus and their unaffected siblings . Arthritis Rheum 2002; 46: 2377-2383 .

51.

Østensen M. Rheumatological disorders . Best Pract & Res Clin Obst Gynaec 2001; 15: 953-969 .

52.

Petri M. Immunosuppressive drug use in pregnancy . Autoimmunity 2003; 36: 51-56 .

53.

Prevot A , Martini S , Guignard JP. In utero exposure to immunosuppressive drugs . Biol Neonate 2002; 81: 73-81 .

54.

Cimaz R , Meregalli E , Biggioggero M et al. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy . Toxicol Lett 2004; 149: 155-162 .

55.

Airò P , Cavazzana I , Danieli E et al. Response to Clostridium tetani toxoid vaccination in children from mothers with autoimmune rheumatic disorders . Lupus 2004; 13: 763-763 (abstract).

56.

Tseng CE , Buyon JP. Neonatal lupus syndromes in pregnancy and rheumatic disease . Rheum Dis Clinics of North America 1997; 23: 31-54 .

57.

Baud O. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants . New Engl J Med 1999; 341: 1190-1196 .

58.

Spinillo A , Viazzo F , Colleoni R et al. Two-years infant neurodevelop-mental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity . American Journal of Obstet and Gynecol 2004; 191: 217-224 .

59.

Brucato A , Li Destri M , Villa PM et al. Normal neuropsycological development of children with congenital complete heart block exposed or not exposed in utero to dexamethasone . Lupus 2004; 9: 762-762 (abstract).

60.

Airò P , Scarsi M , Benicchi T et al. T cells in children with prolonged foetal exposure to glucocorticoids for anti-Ro/SS-A antibody associated with congenital heart block (CHB) . Ann Rheum Dis 2005; 64(Suppl III): 73-73 .

61.

Hughes GRV. The eradication of congenital heart block . Lupus 2004; 13: 1-1 .

62.

Borden MB , Parke A. Antimalarial drugs in Systemic lupus erythematosus: use in pregnancy . Drug Saf 2001; 24: 1055-1063 .

63.

Tincani A , Biasini Rebaioli C , Frassi M et al. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome . Autoimmunity Review 2005; 4: 423-428 .

64.

Costedoat-Chalumeau N , Amoura Z , Duhaut P et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. A study of one hundred thirty-three cases compared with a control group . Arthritis Rheum 2003; 48: 3207-3211 .

65.

Cimaz R , Brucato A , Meregalli E , Muscarà M , Sergi P. Electroretino-grams of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al . Arthritis Rheum 2004; 50: 3056-3057 (letter).

66.

Motta M , Tincani A , Faden D et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation . Journal of Perinatol 2005; 25: 86-89 .